The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pimavanserin Market Research Report 2025
Synopsis
It is an atypical antipsychotic which is approved for the treatment of Parkinson's disease psychosis and is also being studied for the treatment of Alzheimer’s disease psychosis
Global Pimavanserin market is projected to reach US$ 2187.8 million in 2029, increasing from US$ 1504 million in 2022, with the CAGR of 5.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Pimavanserin market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Pimavanserin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
MSN Laboratories
Teva
Zydus Lifesciences
Acadia Pharmaceuticals
Segment by Type
10Mg
17Mg
34Mg
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Pimavanserin report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
It is an atypical antipsychotic which is approved for the treatment of Parkinson's disease psychosis and is also being studied for the treatment of Alzheimer’s disease psychosis
Global Pimavanserin market is projected to reach US$ 2187.8 million in 2029, increasing from US$ 1504 million in 2022, with the CAGR of 5.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Pimavanserin market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Pimavanserin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
MSN Laboratories
Teva
Zydus Lifesciences
Acadia Pharmaceuticals
Segment by Type
10Mg
17Mg
34Mg
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Pimavanserin report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Pimavanserin Market Overview
1.1 Product Overview and Scope of Pimavanserin
1.2 Pimavanserin Segment by Type
1.2.1 Global Pimavanserin Market Value Comparison by Type (2023-2029)
1.2.2 10Mg
1.2.3 17Mg
1.2.4 34Mg
1.3 Pimavanserin Segment by Application
1.3.1 Global Pimavanserin Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Pimavanserin Market Size Estimates and Forecasts
1.4.1 Global Pimavanserin Revenue 2018-2029
1.4.2 Global Pimavanserin Sales 2018-2029
1.4.3 Global Pimavanserin Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Pimavanserin Market Competition by Manufacturers
2.1 Global Pimavanserin Sales Market Share by Manufacturers (2018-2023)
2.2 Global Pimavanserin Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Pimavanserin Average Price by Manufacturers (2018-2023)
2.4 Global Pimavanserin Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Pimavanserin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pimavanserin, Product Type & Application
2.7 Pimavanserin Market Competitive Situation and Trends
2.7.1 Pimavanserin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pimavanserin Players Market Share by Revenue
2.7.3 Global Pimavanserin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pimavanserin Retrospective Market Scenario by Region
3.1 Global Pimavanserin Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Pimavanserin Global Pimavanserin Sales by Region: 2018-2029
3.2.1 Global Pimavanserin Sales by Region: 2018-2023
3.2.2 Global Pimavanserin Sales by Region: 2024-2029
3.3 Global Pimavanserin Global Pimavanserin Revenue by Region: 2018-2029
3.3.1 Global Pimavanserin Revenue by Region: 2018-2023
3.3.2 Global Pimavanserin Revenue by Region: 2024-2029
3.4 North America Pimavanserin Market Facts & Figures by Country
3.4.1 North America Pimavanserin Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Pimavanserin Sales by Country (2018-2029)
3.4.3 North America Pimavanserin Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pimavanserin Market Facts & Figures by Country
3.5.1 Europe Pimavanserin Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Pimavanserin Sales by Country (2018-2029)
3.5.3 Europe Pimavanserin Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pimavanserin Market Facts & Figures by Country
3.6.1 Asia Pacific Pimavanserin Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Pimavanserin Sales by Country (2018-2029)
3.6.3 Asia Pacific Pimavanserin Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pimavanserin Market Facts & Figures by Country
3.7.1 Latin America Pimavanserin Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Pimavanserin Sales by Country (2018-2029)
3.7.3 Latin America Pimavanserin Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pimavanserin Market Facts & Figures by Country
3.8.1 Middle East and Africa Pimavanserin Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Pimavanserin Sales by Country (2018-2029)
3.8.3 Middle East and Africa Pimavanserin Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pimavanserin Sales by Type (2018-2029)
4.1.1 Global Pimavanserin Sales by Type (2018-2023)
4.1.2 Global Pimavanserin Sales by Type (2024-2029)
4.1.3 Global Pimavanserin Sales Market Share by Type (2018-2029)
4.2 Global Pimavanserin Revenue by Type (2018-2029)
4.2.1 Global Pimavanserin Revenue by Type (2018-2023)
4.2.2 Global Pimavanserin Revenue by Type (2024-2029)
4.2.3 Global Pimavanserin Revenue Market Share by Type (2018-2029)
4.3 Global Pimavanserin Price by Type (2018-2029)
5 Segment by Application
5.1 Global Pimavanserin Sales by Application (2018-2029)
5.1.1 Global Pimavanserin Sales by Application (2018-2023)
5.1.2 Global Pimavanserin Sales by Application (2024-2029)
5.1.3 Global Pimavanserin Sales Market Share by Application (2018-2029)
5.2 Global Pimavanserin Revenue by Application (2018-2029)
5.2.1 Global Pimavanserin Revenue by Application (2018-2023)
5.2.2 Global Pimavanserin Revenue by Application (2024-2029)
5.2.3 Global Pimavanserin Revenue Market Share by Application (2018-2029)
5.3 Global Pimavanserin Price by Application (2018-2029)
6 Key Companies Profiled
6.1 MSN Laboratories
6.1.1 MSN Laboratories Corporation Information
6.1.2 MSN Laboratories Description and Business Overview
6.1.3 MSN Laboratories Pimavanserin Sales, Revenue and Gross Margin (2018-2023)
6.1.4 MSN Laboratories Pimavanserin Product Portfolio
6.1.5 MSN Laboratories Recent Developments/Updates
6.2 Teva
6.2.1 Teva Corporation Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Pimavanserin Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Teva Pimavanserin Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Zydus Lifesciences
6.3.1 Zydus Lifesciences Corporation Information
6.3.2 Zydus Lifesciences Description and Business Overview
6.3.3 Zydus Lifesciences Pimavanserin Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Zydus Lifesciences Pimavanserin Product Portfolio
6.3.5 Zydus Lifesciences Recent Developments/Updates
6.4 Acadia Pharmaceuticals
6.4.1 Acadia Pharmaceuticals Corporation Information
6.4.2 Acadia Pharmaceuticals Description and Business Overview
6.4.3 Acadia Pharmaceuticals Pimavanserin Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Acadia Pharmaceuticals Pimavanserin Product Portfolio
6.4.5 Acadia Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pimavanserin Industry Chain Analysis
7.2 Pimavanserin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pimavanserin Production Mode & Process
7.4 Pimavanserin Sales and Marketing
7.4.1 Pimavanserin Sales Channels
7.4.2 Pimavanserin Distributors
7.5 Pimavanserin Customers
8 Pimavanserin Market Dynamics
8.1 Pimavanserin Industry Trends
8.2 Pimavanserin Market Drivers
8.3 Pimavanserin Market Challenges
8.4 Pimavanserin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
